Pharmafile Logo

Free Thinking – US Presidential Election: The legacy of the Affordable Care Act and the future for healthcare

October 31, 2016 | US healthcare 

Our latest Free Thinking white paper explores the legacy of the Affordable Care Act and the future for healthcare

Our latest Free Thinking white paper explores the legacy of the Affordable Care Act and the future for healthcareAs US citizens prepare to vote for a new President on Tuesday 8th November, we ask, what is the likely impact of a Republican or Democrat win on the future of the ACA, the health system and the pharma industry?

We spoke to John Leifer, author and strategic consultant to the healthcare industry, to see which way he thinks the wind is blowing. 

Download our complimentary Free Thinking white paper which looks at:

– The Affordable Care Act: in principle and practice
– Where the candidates stand
– The impact of recent pricing scandals
– The effect on pharma
– The need to demonstrate real long-term value

http://www.researchpartnership.com/news/2016/10/free-thinking-us-presidential-election-future-for-he…

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Infographic: North Asia

An overview of the five most-commonly researched, largest pharma markets in North Asia.

Infographic: PsO market snapshot

An overview of the PsO biologic and systemic patientOur PsO market snapshot offers an introduction to the real world patient data collected by our Therapy Watch PsO study. The snapshot...

Infographic: Prostate Cancer Market Snapshot

An overview of the prostate cancer patientDownload our Therapy Watch PCa market snapshot which provides you with an overview of the prostate cancer patient and the therapy regimens followed by...

Infographic: LATAM

Latin AmericaThe LATAM regions largest markets of Argentina, Brazil, Chile, Colombia, Mexico and Venezuela, is home to more than 460 million people and is a key global growth region. With...

Infographic: RA market snapshot

An overview of the RA biologic patientOur RA market snapshot will provide you with an introduction to the treatment pathways followed by RA patients treated with biologic agents. Our analyses...

Infographic: CEE

The Central and Eastern Europe region is home to over 145 million people and is a key global growth region. With pharmaceutical sales set to exceed $27bn in 2014, it...

Infographic: ASEAN-6

Home to over half a billion people, the ASEAN region constitutes the eighth largest economy in the world. With pharmaceutical sales projected to exceed $20 billion in 2014, it’s an...

Infographic: HCV – The Roadblocks to Effective Treatment

Referencing data from our Living with HCV survey undertaken with patients in the US and China, this infographic explores the roadblocks encountered on the path to effective and compliant treatment.Hepatitis C is...

Turkey: Identifying the Growth Drivers

Published in eye for pharma 3 April by Marc Yates

Article: The Patient Abroad

Published in Medical Marketing & Media March 2015